Home > Stakeholders > Pharmaceutical Manufacturers

Pharmaceutical Manufacturers

Increase brand adherence and persistency

For pharmaceutical companies, low medication adherence amounts to $177 billion in lost revenue per year, representing about one-quarter of total annual pharmaceutical revenues and an average per drug loss of 36 percent in potential sales. And 50% of those living with one or more chronic illnesses are non-compliant, resulting in even greater revenue losses.

iReminder’s Compliance for Life (CFL) is a medication adherence and coaching system to keep patients on their therapy. It sends to patients educational and support messages, reminders and regimen instructions. CFL substantially increases new and total refills and sharply reduces initial drop off in adherence rates after the first fills. This patient support program is branded to conform to each drug’s branding program.

Manage Risk

Automated communications between healthcare providers, patients and pharmacies help pharmaceutical brands better manage risk. Drugs with Risk Evaluation Mitigation Strategies (REMS) and Elements to Assure Safe Use (ETASU) can now offer stakeholders automated and traceable communications regarding scheduled laboratory testing, appointments and refills.

MedTrigger provides a comprehensive ETASU program that reminds patients to comply with all events required by their risk management plan (e.g. lab tests, physician appointments, medication injections) and reports their level of compliance to prescribers and pharmacists. It provides a comprehensive, 360 degree view of each patient's compliance across different tasks.

For Pharmaceutical manufacturers, iReminder delivers a wide-range of solutions:

  • Adherence support
  • Brand Awareness
  • Brand Benefits
  • REMS ETASU solutions
  • Education on drugs and disease states
  • Coaching programs

Contact iReminder to discuss how we can increase loyalty to your brand and enhance REMS programs.

Medication Adherence Statistics

  • 49% of consumers who look online for pharmaceutical information are interested in email or text reminders for prescription refills
  • Among patients with diabetes, those with lower levels of adherence have nearly twice the total annual healthcare costs of those with high levels of adherence ($16,498 versus $8,886)
  • Better adherence to anti-hypertensive treatment alone could prevent 89,000 premature deaths in the United States annually
  • Designed and implemented properly, a REMS program protects patients from known or potential serious risks
.
.

.
.
.
.
.
.